Markets:

Overview

News

Currencies

International

Treasuries

Avicanna Inc (OP:AVCNF)

0.0959 +0.0209 (+27.87%)

Streaming Delayed Price Updated: 9:39 AM EDT, Jul 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Avicanna Inc

< Previous 1 2 3 4 5 Next >

Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing

March 13, 2026

From Virtual Investor Conferences

Via GlobeNewswire

Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th

March 10, 2026

Company Executives Share Strategic Vision and Engage with Investors Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

World's Largest Tobacco Company Is Investing In Medical Cannabis: Here's What To Know ↗

May 13, 2025

Philip Morris is expanding its medical cannabis strategy via Aurora and Avicanna. What it means for the future of Big Tobacco in the cannabinoid space.

Via Benzinga

Topics Cannabis

This Week In Cannabis: Carmelo's NY Launch, Federal Reform, Cancer Study, Avicanna's Growth, Tilray's Split, DeSantis Fallout, Slovenia's Big Move And More ↗

April 18, 2025

Cannabis news this week: Congress revives cannabis reform, Slovenia leads Europe, Tyson takes charge and science backs cannabis for cancer care.

Via Benzinga

Topics Cannabis

Why Cannabis-Focused Biopharma Co. Avicanna Traded Up 26%+ Today ↗

April 14, 2025

Shares of Avicanna Inc.

Via Benzinga

The Week In Cannabis: Delays, Decrees And Deals Reshape The Global Playbook ↗

April 11, 2025

Cannabis news of the week: Germany holds CanG, US delays, Chile bill; Italy hemp ban; SNDL expands, Tilray cuts outlook, US sales forecast –$21 B.

Via Benzinga

Topics Cannabis

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing

March 14, 2025

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

Life Sciences Investor Forum Agenda Announced for March 13th

March 12, 2025

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

This Week In Cannabis: Rescheduling Delays, The DEA, Biden's Clemency, Philip Morris' New Bet And More ↗

January 17, 2025

Cannabis news: DEA delays reform hearings, Florida renews legalization push and global markets expand.

Via Benzinga

Topics Cannabis

Avicanna Reduces Net Loss And Improves Gross Profit, Focusing On International Markets ↗

November 15, 2024

Via Benzinga

Cannabis Flower Sales In Colombia And The Small Producer Protection Myth: Ex-Official Says Most Companies Qualify ↗

October 24, 2024

Colombia's cannabis decree allows dry flower sales, but ex-official claims it won't just protect small producers—most companies may qualify.

Via Benzinga

Topics Cannabis

CBD's Toxicity Concerns: Could Europe Ban Cannabidiol In Cosmetics? ↗

September 23, 2024

CBD could be deemed toxic for reproduction, which would then lead to its prohibition in cosmetic products across Europe.

Via Benzinga

Avicanna Secures Nearly $2M In Private Placement Deal Amid US Patent Win For Cannabinoid Topical Formula ↗

August 29, 2024

Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) announced on Thursday that it has closed a non-brokered private placement offering of its 6,620,692 ‎‎units at $0.30 per unit for aggregate gross...

Via Benzinga

Topics Intellectual Property

Avicanna Secures US Patent For Topical Cannabinoid Technology To Treat Pain And Inflammation ↗

August 27, 2024

Avicanna secures a U.S. patent for its innovative deep penetrating topical cannabinoid composition for treating pain and inflammation.

Via Benzinga

Topics Intellectual Property

Avicanna's CBG Products Reach 19 Countries: Denmark Joins Global Expansion ↗

August 15, 2024

Avicanna Inc. (OTC: AVCNF) biopharmaceutical company announced Thursday the successful export of its Aureus-branded cannabigerol (CBG) products to Denmark.

Via Benzinga

Avicanna Q2 Revenue Improves 85% YoY, Cannabis Company Touts Two Successful Trials On Drug Candidates ↗

August 15, 2024

Via Benzinga

Topics Cannabis

Latest Cannabis Hires And Board Changes, Here's What You Need To Know ↗

July 12, 2024

Cannabis ancillary company EnWave Corporation (TSX-V: ENW) (FSE: E4U) announced on Thursday that it had tapped Danna Dunnage as its new vice president of global sales and business development. Dunnage...

Via Benzinga

Topics Cannabis

Avicanna Exports Cannabinoids To Singapore Legally — Even Though Cannabis Is Punishable By Death In The Country ↗

July 11, 2024

Cannabinoid-focused biopharmaceutical company Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) announced on Thursday that through its majority-owned subsidiary Santa Marta Golden Hemp the company...

Via Benzinga

Topics Cannabis

Life Science Virtual Investor Forum Presentations Now Available for Online Viewing

June 21, 2024

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

Life Sciences Virtual Investor Forum Agenda Announced for June 20th

June 18, 2024

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

CBD-Focused Avicanna Reports First-Ever Adjusted EBITDA Positive Quarter, 451% YoY Spike In Q1 Record Revenue ↗

May 14, 2024

Cannabis-focused biopharmaceutical company Avicanna Inc. announced on Tuesday financial results for the first quarter of fiscal 2024.CEO Aras Azadian called it its "best quarter." In addition to being...

Via Benzinga

CBD Helps With This Rare Blistering Skin Disorder, New Study From Avicanna Shows Promising Results In Epidermolysis Bullosa Treatment ↗

May 13, 2024

There is no cure for a rare blistering skin disorder called Epidermolysis Bullosa (EB). But, treatments to help alleviate and control the symptoms do exist. The growing body of research suggests...

Via Benzinga

Topics Cannabis

Cannabinoid-Based Products Maker Sees Triple-Digit Growth In 2023 Gross Profit, Revenue Surges 314% YoY ↗

April 02, 2024

Cannabinoids-focused biopharmaceutical company Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) reported on Tuesday year-end 2023 results and audited financial statements. The Canadian company...

Via Benzinga

Topics Cannabis

This Company Is Bringing Medical Marijuana Telehealth To Over Half The U.S. ↗

March 01, 2024

MMJ.com, a telehealth platform providing access to medical marijuana, has expanded its services to 26 states. This expansion allows patients to consult state-certified doctors online for medical...

Via Benzinga

Topics Cannabis

Can Cannabis Treat Severe Forms Of Epilepsy? New Medicine Sparks Hope As Colombia's Weed Industry Goes Global ↗

February 14, 2024

Clever Leaves Holdings Inc.

Via Benzinga

Topics Cannabis

CBD-Focused Avicanna Taps Into European Market Via Exclusive Pharma Supply Deal ↗

February 05, 2024

Canadian cannabinoid-based biopharmaceutical firm Avicanna will supply two proprietary topical products to an unnamed multinational pharmaceutical firm in six European countries in 2024. The deal will...

Via Benzinga

CBD-Focused Avicanna Announces Funding Boost For Research And Development ↗

December 05, 2023

Cannabinoid-based biopharmaceutical company Avicanna Inc.

Via Benzinga

Avicanna Inc.: Medical Marijuana Sales Reach Record 713% YoY Growth In Q3, Introduces New Platform ↗

November 14, 2023

Avicanna Inc. (OTCQX: AVCNF) a biopharmaceutical company specializing in proprietary cannabinoid-based products, announced Q3 2023 results late Tuesday, highlighted by the successful acquisiti

Via Benzinga

Topics Cannabis

Cannabis Stock Gainers And Losers From August 25, 2023 ↗

August 25, 2023

Via Benzinga

Topics Cannabis

Marijuana Stock Movers For August 23, 2023 ↗

August 23, 2023

Via Benzinga

Topics Cannabis

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.